January 21, 2026 – The Japan Pharmaceutical Manufacturers Association (JPMA) has joined forces with INCATE (INCubator for Antimicrobial Therapies in Europe), strengthening global collaboration to support innovation and solutions against antimicrobial resistance (AMR). INCATE brings [...]
More news
Unison Medicines is delighted to announce an oversubscribed first close of $500k of financing from [...]
We are happy to announce a new partnership with Granzer Regulatory Consulting & Services GmbH [...]
From bone flutes to synths, music has always been more than noise — it’s how [...]
The INCATE Selection Committee has chosen four new ventures for Stage I support. Meet the [...]
Did you know phages helped stop a cholera outbreak in Stalingrad during WWII? While antibiotics [...]
In 2025, it is possible — and increasingly common — to treat cancer but lose [...]
At INCATE, we are committed to providing support to early-stage innovators working on antimicrobial resistance [...]
On February 7, 2025, Swiss biopharmaceutical innovator BioVersys made its debut on the SIX Swiss [...]
